Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain.

Sun W, Xie C, Wang H, Hu Y.

Biomaterials. 2004 Jul;25(15):3065-71.

PMID:
14967540
2.

Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies.

Jain D, Bajaj A, Athawale R, Shrikhande S, Goel PN, Nikam Y, Gude R, Patil S, Prashant Raut P.

Drug Deliv. 2016;23(3):999-1016. doi: 10.3109/10717544.2014.926574. Epub 2014 Jul 15.

PMID:
25026415
3.

The synthesis and characterization of polymer coated iron oxide microspheres.

Ramanujan RV, Chong WT.

J Mater Sci Mater Med. 2004 Aug;15(8):901-8.

PMID:
15477742
5.

Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.

Mittal G, Carswell H, Brett R, Currie S, Kumar MN.

J Control Release. 2011 Mar 10;150(2):220-8. doi: 10.1016/j.jconrel.2010.11.013. Epub 2010 Nov 24.

PMID:
21111014
6.

In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles.

Bommana MM, Kirthivasan B, Squillante E.

Drug Deliv. 2012 Aug;19(6):298-306. doi: 10.3109/10717544.2012.714812. Epub 2012 Aug 28.

PMID:
22928708
7.

The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.

Weiss CK, Kohnle MV, Landfester K, Hauk T, Fischer D, Schmitz-Wienke J, Mailänder V.

ChemMedChem. 2008 Sep;3(9):1395-403. doi: 10.1002/cmdc.200800130.

PMID:
18613205
8.

Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro.

Alyaudtin RN, Reichel A, Löbenberg R, Ramge P, Kreuter J, Begley DJ.

J Drug Target. 2001 Jun;9(3):209-21.

PMID:
11697206
9.

Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.

Fahmy TM, Samstein RM, Harness CC, Mark Saltzman W.

Biomaterials. 2005 Oct;26(28):5727-36. Epub 2005 Apr 18.

PMID:
15878378
10.

Effects of apolipoproteins on dalargin transport across the blood-brain barrier.

Shamenkov DA, Petrov VE, Alyautdin RN.

Bull Exp Biol Med. 2006 Dec;142(6):703-6. English, Russian.

PMID:
17603675
11.

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

Ravi Kumar MN, Bakowsky U, Lehr CM.

Biomaterials. 2004 May;25(10):1771-7.

PMID:
14738840
12.

Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.

Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K.

Biomaterials. 2005 May;26(15):2723-32.

PMID:
15585276
13.

Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.

Gupta AK, Berry C, Gupta M, Curtis A.

IEEE Trans Nanobioscience. 2003 Dec;2(4):255-61.

PMID:
15376916
14.
15.

An attempt to directly trace polymeric nanoparticles in vivo with electron microscopy.

Sun W, Wang H, Xie C, Hu Y, Yang X, Xu H.

J Control Release. 2006 Oct 27;115(3):259-65. Epub 2006 Aug 17.

PMID:
17010467
16.

Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles.

Nimesh S, Manchanda R, Kumar R, Saxena A, Chaudhary P, Yadav V, Mozumdar S, Chandra R.

Int J Pharm. 2006 Oct 12;323(1-2):146-52. Epub 2006 Jul 7.

PMID:
16920286
17.

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R.

J Drug Target. 2002 Jun;10(4):317-25.

PMID:
12164380
18.

Delivery of nanoparticles to the brain detected by fluorescence microscopy.

Reimold I, Domke D, Bender J, Seyfried CA, Radunz HE, Fricker G.

Eur J Pharm Biopharm. 2008 Oct;70(2):627-32. doi: 10.1016/j.ejpb.2008.05.007. Epub 2008 Jun 5.

PMID:
18577452
20.

Supplemental Content

Support Center